Aclaris Therapeutics, Inc. 4
4 · Aclaris Therapeutics, Inc. · Filed Oct 6, 2015
Insider Transaction Report
Form 4
Bierly Rick
Director
Transactions
- Award
Stock Option (right to buy)
2015-10-06+17,800→ 17,800 totalExercise: $11.00Exp: 2025-10-05→ Common Stock (17,800 underlying)
Footnotes (1)
- [F1]The shares underlying this option will vest in a series of 36 equal monthly installments, subject to the reporting person's continuous service with the Issuer as of each such vesting date.